Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lisata Therapeutics, Inc. - Common Stock (NQ: LSTA ) 2.914 -0.016 (-0.54%) Streaming Delayed Price Updated: 3:22 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Lisata Therapeutics, Inc. - Common Stock LSTA Stock Earnings: Lisata Therapeutics Beats EPS for Q2 2024 August 12, 2024 LSTA stock results show that Lisata Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace EXCLUSIVE: Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD Technology To Evaluate Pancreatic Cancer Therapy Efficacy July 18, 2024 Haystack Oncology, a Quest Diagnostics company, and Lisata Therapeutics collaborate to use Haystack MRD technology in a study of certepetide plus chemotherapy for metastatic pancreatic cancer, focusing... Via Benzinga Lisata Therapeutics gets 2024 off to a strong start as it prepares for crucial ASCEND trial results May 13, 2024 Lisata Therapeutics gets 2024 off to a strong start as it prepares for crucial ASCEND trial results Via News Direct Exposures Product Safety LSTA Stock Earnings: Lisata Therapeutics Beats EPS for Q1 2024 May 09, 2024 LSTA stock results show that Lisata Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Recap: Lisata Therapeutics Q4 Earnings February 29, 2024 Via Benzinga Earnings Scheduled For February 29, 2024 February 29, 2024 Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. Via Benzinga Lisata Therapeutics's Earnings Outlook February 28, 2024 Via Benzinga Earnings Preview: Lisata Therapeutics November 01, 2023 Via Benzinga Earnings Scheduled For August 14, 2023 August 14, 2023 Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million. Via Benzinga Earnings Scheduled For March 30, 2023 March 30, 2023 Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday December 13, 2022 On Tuesday, 49 companies hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday December 23, 2022 OnFriday, 143 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday December 14, 2022 On Wednesday, 115 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday October 18, 2022 During Tuesday's session, 78 companies made new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 16, 2022 Via Benzinga 121 Stocks That Hit Their 52-Week Low October 14, 2022 New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows. Via Benzinga Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday September 19, 2022 Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday. Via Benzinga Why NCR Is Trading Lower By Around 23%, Here Are 42 Stocks Moving In Friday's Mid-Day Session September 16, 2022 Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) jumped 35.4% to $13.54 after gaining 11% on Thursday. Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.